VRNA - Verona Pharma Plc - ADR
IEX Last Trade
27.49
1.480 5.384%
Share volume: 1,225,274
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$26.01
1.48
5.69%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-03 | 2022-08-09 | 2022-11-09 | 2023-03-07 | 2023-05-09 | 2023-08-03 | 2023-11-02 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 458.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 346.000 K | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 112.000 K | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | inf% | -100.00% | nan% | nan% | |||
| Operating expenses | 23.763 M | 15.099 M | 13.001 M | 14.365 M | 19.886 M | 11.899 M | 16.620 M | |
| Selling general and admin | 7.440 M | 5.526 M | 5.290 M | 8.323 M | 9.589 M | 12.439 M | 13.353 M | |
| Research and development | 16.323 M | 9.573 M | 7.711 M | 6.042 M | 10.297 M | -540.000 K | 3.267 M | |
| Total expenses | 23.763 M | 15.099 M | 13.001 M | 14.711 M | 19.886 M | 11.899 M | 16.620 M | |
| -36.46% | -13.89% | 13.15% | 35.18% | -40.16% | 39.68% | |||
| Operating income | -23.763 M | -15.099 M | -13.001 M | -14.253 M | -19.886 M | -11.899 M | -16.620 M | |
| Ebit | -23.763 M | -15.099 M | -13.001 M | -14.253 M | -19.886 M | -11.899 M | -16.620 M | |
| Pretax income | -24.755 M | -17.687 M | -15.583 M | -10.423 M | -16.570 M | -8.497 M | -14.643 M | |
| -28.55% | -11.90% | -33.11% | 58.98% | -48.72% | 72.33% | |||
| Income tax | 82.000 K | 79.000 K | 64.000 K | 28.000 K | 173.000 K | 310.000 K | 44.000 K | |
| Net income basic | -24.837 M | -17.766 M | -15.647 M | -10.451 M | -16.743 M | -8.807 M | -14.687 M | |
| 28.47% | 11.93% | 33.21% | -60.20% | 47.40% | -66.77% | |||
| Net income | -24.837 M | -17.766 M | -15.647 M | -10.451 M | -16.743 M | -8.807 M | -14.687 M | |
| 28.47% | 11.93% | 33.21% | -60.20% | 47.40% | -66.77% |